Venture • Life Science

Kotak Private Equity Group, ChrysCapital and Capital Group Private Markets Invest In Intas Pharmaceuticals

On January 1, 2005, private equity firms Kotak Private Equity Group, ChrysCapital and Capital Group Private Markets invested in life science company Intas Pharmaceuticals

Investment Context
  • This is Kotak Private Equity Group’s 1st, ChrysCapital’s 1st and Capital Group Private Markets’ 1st transaction in the Life Science sector.
  • This is Kotak Private Equity Group’s 2nd, ChrysCapital’s 9th and Capital Group Private Markets’ 1st transaction in India.

Explore All 557 Venture Life Science Deals - Search the Database Free


Investment Summary

Date January 1, 2005
Target Intas Pharmaceuticals
Sector Life Science
Investor(s) Kotak Private Equity Group
ChrysCapital
Capital Group Private Markets
Deal Type Venture

Target Company

Intas Pharmaceuticals

Ahmedabad, India
Intas Pharmaceuticals is a vertically integrated Indian pharmaceutical company committed to delivering affordable and innovative pharmaceutical solutions. Intas Pharmaceuticals is based in Ahmedabad, Gujarat.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investors Overview 3

Investor

Kotak Private Equity Group

Mumbai, India

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2005
PE ASSETS 1.4B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Kotak Private Equity Group (KPEG) is the private equity investment arm of financial services firm, Kotak Mahindra Group. KPEG looks to invest $20 to $40 million in a variety of mid-sized Indian companies to support expansion, acquisitions, or buyouts KPEG targets businesses with strong management and growth potential operating in fragmented industries. Sectors of interest include life science, retail, media/entertainment, light manufacturing, agriculture, food processing, healthcare, distribution, and IT/software. Kotak is based in Mumbai.


Deal Context for Investor #
Overall 2 of 26
Sector: Life Science 1 of 7
Type: Venture 1 of 1
Country: India 2 of 26
Year: 2005 1 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2003-01-01 Divi s Laboratories

Hyderabad, India

Divi's Laboratories focussed on developing new processes for the production of Active Pharma Ingredients (APIs) & Intermediates. The company in a matter of short time expanded its breadth of operations to provide complete turnkey solutions to the domestic Indian pharmaceutical industry. Divi's Laboratories was founded in 1990 and is based in Hyderabad, Telangana.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-06-24 ING Vysya Bank

Bengaluru, India

ING Vysya Bank is one of the oldest private sector banks in India with an 81 year long history offering a wide variety of wholesale, retail and private banking products and services over two million customers. ING is amongst the top 10 largest private sector banks in India in terms of deposits and advances.

Buy -
Investor

ChrysCapital

Port Louis, Mauritius

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1999
PE ASSETS 5.0B USD
Size Large
Type Sector Agnostic
DESCRIPTION

ChrysCapital Management Co. is a private investment firm focused on opportunities in India. ChrysCapital looks for companies with revenues of $50 million to $1 billion and can commit up to $250 million of equity per transaction. Target sectors include business services, consumer goods and services, financial services, healthcare and pharmaceuticals. Prospective transactions include growth investments in private and listed companies, special situations, co-investments, and management buyouts/buy-ins. ChrysCapital was formed in 1999 and is based in Port Louis, Mauritius.


Deal Context for Investor #
Overall 11 of 54
Sector: Life Science 1 of 7
Type: Venture 2 of 5
Country: India 9 of 45
Year: 2005 2 of 6
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-01-01 Balakrishna Industries

Mumbai, India

Balakrishna Industries is a niche low-cost tyre manufacturer focused on manufacturing & exports of off-the-road (OTR) tyres. The Company has an extensive network of distributors across 75 countries and 95% of revenues are derived from exports. Balkrishna also sells to a number of prominent OEMs like JCB, Terex, Ingersoll Rand and Case New Holland. Balakrishna Industries was founded in 1961 and is based in Mumbai, India.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-01-05 Shriram Finance

Mumbai, India

Shriram Finance is a finance provider for the commercial vehicle industry with a focus on providing credit facilities to small truck owners. Shriram Finance was founded in 1979 and is based in Mumbai, India.

Buy -
Investor
DESCRIPTION

Capital Group Private Markets is the direct investment arm of asset manager Capital Group. Capital Group Private Markets pursues expansion stage company investments in emerging markets with a focus on companies that locally dominate their respective markets. Capital Group Private Markets generally seeks minority positions, but will consider select control situations as well. Capital Group Private Markets was formed in 1992 and is headquartered in San Francisco, California.


Deal Context for Investor #
Overall 1 of 17
Sector: Life Science 1 of 3
Type: Venture 1 of 2
Country: India 1 of 3
Year: 2005 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2008-08-01 Seven Energy

London, United Kingdom

Seven Energy is an oil and gas infrastructure company operating in the Niger Delta. The company has two lines of onshore operations in Nigeria – upstream oil & gas exploration (appraisal, development and production) and midstream gas processing (distribution, sales and marketing). Seven Energy International was founded in 2004 and is based in London, United Kingdom.

Buy -

Explore Related M&A Activity